Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Elevance Health, Inc. (ELV) EV/EBITDA

As of 25 September 2026, Elevance Health, Inc. (ELV) trades at a EV/EBITDA of 9.0×. Over the past ten years it has ranged from 3.8× (November 2016) to 11.6× (July 2021); the current reading is higher than 61% of that period. That is below the Healthcare Plans industry median of 10.9× and below the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 7.7× (1.25%)
FY2024 7.8× (19.47%)
FY2023 9.7× (11.01%)
FY2022 10.9× 7.04%
FY2021 10.2× 19.43%
FY2020 8.5× (5.70%)
FY2019 9.0× (0.49%)
FY2018 9.1× 1.04%
FY2017 9.0× 90.50%
FY2016 4.7× (5.58%)

Quarterly

Period EV/EBITDA Change
Jun 2026 8.8× 37.85%
Mar 2026 6.4× (17.13%)
Dec 2025 7.7× 13.55%
Sep 2025 6.8× (19.04%)
42 more quarters

Against its own ten years

Low 3.8× High 11.6×
Ten-year median 8.5×
Current reading's percentile 61

EV/EBITDA against peers

Company EV/EBITDA
CLOV Clover Health Investments, Corp. compare n/m
CNC Centene Corporation compare n/m
CI Cigna Group compare 7.7×
OSCR Oscar Health, Inc. compare 8.4×
CVS CVS Health Corporation compare 8.7×
ELV Elevance Health, Inc. 9.0×
HUM Humana Inc. compare 10.9×
MOH Molina Healthcare, Inc compare 13.0×
UNH UnitedHealth Group Incorporated compare 14.5×
Healthcare Plans industry median 10.9×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ELV